These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes. Garratt CJ; Elliott P; Behr E; Camm AJ; Cowan C; Cruickshank S; Grace A; Griffith MJ; Jolly A; Lambiase P; McKeown P; O'Callagan P; Stuart G; Watkins H; Europace; 2010 Aug; 12(8):1156-75. PubMed ID: 20663787 [TBL] [Abstract][Full Text] [Related]
8. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
9. [The clinical practice guidelines of the Sociedad Española de Cardiología on the automatic implantable defibrillator]. Pérez-Villacastín J; Carmona Salinas JR; Hernández Madrid A; Marín Huerta E; Merino Llorens JL; Ormaetxe Merodio J; Moya i Mitjans A Rev Esp Cardiol; 1999 Dec; 52(12):1083-104. PubMed ID: 10659655 [TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter defibrillators in cardiovascular practice: report of the policy conference of the North American Society of Pacing and Electrophysiology. J Interv Cardiol; 1991; 4(3):211-20. PubMed ID: 10160988 [No Abstract] [Full Text] [Related]
14. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines. Bennett M; Parkash R; Nery P; Sénéchal M; Mondesert B; Birnie D; Sterns LD; Rinne C; Exner D; Philippon F; Campbell D; Cox J; Dorian P; Essebag V; Krahn A; Manlucu J; Molin F; Slawnych M; Talajic M Can J Cardiol; 2017 Feb; 33(2):174-188. PubMed ID: 28034580 [TBL] [Abstract][Full Text] [Related]
16. [Implantable cardioverter defibrillator]. Tanaka S; Ikeshita M; Shoji T Kokyu To Junkan; 1993 Apr; 41(4):357-63. PubMed ID: 8516574 [No Abstract] [Full Text] [Related]
17. Infrequent physician use of implantable cardioverter-defibrillators risks patient safety. Lyman S; Sedrakyan A; Do H; Razzano R; Mushlin AI Heart; 2011 Oct; 97(20):1655-60. PubMed ID: 21795298 [TBL] [Abstract][Full Text] [Related]
18. Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices Anesthesiology; 2005 Jul; 103(1):186-98. PubMed ID: 15983472 [No Abstract] [Full Text] [Related]
19. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions. Verma N; Rhyner J; Knight BP Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601 [TBL] [Abstract][Full Text] [Related]